Cost-Effectiveness of Hybrid PET/CT for Staging of Non-Small Cell Lung Cancer

Jonas Schreyögg*, Julia Weller, Tom Stargardt, Ken Herrmann, Christina Bluemel, Tobias Dechow, Gerhard Glatting, Bernd J. Krause, Felix Mottaghy, Sven N. Reske, Andreas K. Buck

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1668-1675
JournalJournal of Nuclear Medicine
Volume51
Issue number11
DOIs
Publication statusPublished - Nov 2010

Keywords

  • cost-effectiveness analysis
  • quality-adjusted life year
  • hybrid PET/CT
  • non-small cell lung cancer

Cite this